Triphase to present Marizomib clinical and preclinical data at American Society of Hematology’s annual meeting
TORONTO and SAN DIEGO (December 8, 2015) — Triphase Accelerator Corporation, a private drug development company dedicated to advancing novel compounds through Phase 2 proof-of-concept, today announced that positive results…